{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T05:41:12Z","timestamp":1793166072893,"version":"4.5.0"},"reference-count":127,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019180","name":"HORIZON EUROPE European Research Council","doi-asserted-by":"publisher","award":["101071386"],"award-info":[{"award-number":["101071386"]}],"id":[{"id":"10.13039\/100019180","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Immunology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.smim.2025.101946","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T13:18:41Z","timestamp":1743427121000},"page":"101946","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Variable domain glycosylation as a marker and modulator of immune responses: Insights into autoimmunity and B-cell malignancies"],"prefix":"10.1016","volume":"78","author":[{"given":"Roxane","family":"Biersteker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver F.","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Wuhrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom W.J.","family":"Huizinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9 E.M.","family":"Toes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Hafkenscheid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.smim.2025.101946_bib1","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.jaci.2009.09.046","article-title":"Structure and function of immunoglobulins","volume":"125","author":"Schroeder","year":"2010","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2025.101946_bib2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000235071","article-title":"Biological role of different antibody classes","volume":"90","author":"Spiegelberg","year":"1989","journal-title":"Int Arch. Allergy Appl. Immunol."},{"issue":"5","key":"10.1016\/j.smim.2025.101946_bib3","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.sbi.2011.08.005","article-title":"Mechanisms and principles of N-linked protein glycosylation","volume":"21","author":"Schwarz","year":"2011","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.smim.2025.101946_bib4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3389\/fimmu.2020.00241","article-title":"A comparison of immunoglobulin variable region N-linked glycosylation in healthy donors, autoimmune disease and lymphoma","volume":"11","author":"Vletter","year":"2020","journal-title":"Front. Immunol."},{"issue":"7-8","key":"10.1016\/j.smim.2025.101946_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejcb.2021.151186","article-title":"Advances in understanding N-glycosylation structure, function, and regulation in health and disease","volume":"100","author":"Esmail","year":"2021","journal-title":"Eur. J. Cell Biol."},{"issue":"1","key":"10.1016\/j.smim.2025.101946_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev.immunol.25.022106.141702","article-title":"The impact of glycosylation on the biological function and structure of human immunoglobulins","volume":"25","author":"Arnold","year":"2007","journal-title":"Annu. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.smim.2025.101946_bib7","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.it.2022.08.001","article-title":"Afucosylated IgG responses in humans\u2013structural clues to the regulation of humoral immunity","volume":"43","author":"Oosterhoff","year":"2022","journal-title":"Trends Immunol."},{"issue":"6","key":"10.1016\/j.smim.2025.101946_bib8","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.4049\/jimmunol.2100399","article-title":"Fc galactosylation promotes hexamerization of human IgG1, leading to enhanced classical complement activation","volume":"207","author":"van Osch","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2025.101946_bib9","doi-asserted-by":"crossref","unstructured":"Wei, B., et al. Fc galactosylation follows consecutive reaction kinetics and enhances immunoglobulin G hexamerization for complement activation. in MAbs. 2021. Taylor & Francis.","DOI":"10.1080\/19420862.2021.1893427"},{"issue":"4","key":"10.1016\/j.smim.2025.101946_bib10","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.4049\/jimmunol.1502136","article-title":"The Emerging Importance of IgG Fab Glycosylation in Immunity","volume":"196","author":"van de Bovenkamp","year":"2016","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.smim.2025.101946_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021246","article-title":"Enrichment of sialylated IgG by lectin fractionation does not enhance the efficacy of immunoglobulin G in a murine model of immune thrombocytopenia","volume":"6","author":"Guhr","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.smim.2025.101946_bib12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1021\/bp040016j","article-title":"Glycosylation of recombinant antibody therapeutics","volume":"21","author":"Jefferis","year":"2005","journal-title":"Biotechnol. Prog."},{"key":"10.1016\/j.smim.2025.101946_bib13","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10875-010-9409-2","article-title":"Analytical and functional aspects of antibody sialylation","volume":"30","author":"Stadlmann","year":"2010","journal-title":"J. Clin. Immunol."},{"issue":"11","key":"10.1016\/j.smim.2025.101946_bib14","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1074\/mcp.M114.039537","article-title":"Immunoglobulin G (IgG) Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes","volume":"13","author":"Bondt","year":"2014","journal-title":"Mol. Cell. Proteom."},{"issue":"6","key":"10.1016\/j.smim.2025.101946_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037243","article-title":"Analysis and functional consequences of increased Fab-sialylation of intravenous immunoglobulin (IVIG) after lectin fractionation","volume":"7","author":"K\u00e4sermann","year":"2012","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.smim.2025.101946_bib16","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.jaci.2022.10.035","article-title":"Differences in IgG autoantibody Fab glycosylation across autoimmune diseases","volume":"151","author":"Koers","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"issue":"8","key":"10.1016\/j.smim.2025.101946_bib17","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1073\/pnas.1711720115","article-title":"Adaptive antibody diversification through N-linked glycosylation of the immunoglobulin variable region","volume":"115","author":"Van De Bovenkamp","year":"2018","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.smim.2025.101946_bib18","article-title":"Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis","volume":"18","author":"Gibofsky","year":"2012","journal-title":"Am. J. Manag. care"},{"issue":"2","key":"10.1016\/j.smim.2025.101946_bib19","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1074\/mcp.M116.062919","article-title":"Structural analysis of variable domain glycosylation of anti-citrullinated protein antibodies in rheumatoid arthritis reveals the presence of highly sialylated glycans","volume":"16","author":"Hafkenscheid","year":"2017","journal-title":"Mol. Cell. Proteom."},{"issue":"11","key":"10.1016\/j.smim.2025.101946_bib20","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1002\/art.39273","article-title":"Association of systemic lupus erythematosus with decreased immunosuppressive potential of the IgG glycome","volume":"67","author":"Vu\u010dkovi\u0107","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"3","key":"10.1016\/j.smim.2025.101946_bib21","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1046\/j.1523-1755.2000.057003846.x","article-title":"Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features","volume":"57","author":"Savige","year":"2000","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.smim.2025.101946_bib22","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.smim.2025.101946_bib23","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1136\/annrheumdis-2014-206598","article-title":"Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis","volume":"75","author":"Rombouts","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"17","key":"10.1016\/j.smim.2025.101946_bib24","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1002\/pmic.200800931","article-title":"A close look at human IgG sialylation and subclass distribution after lectin fractionation","volume":"9","author":"Stadlmann","year":"2009","journal-title":"Proteomics"},{"issue":"11","key":"10.1016\/j.smim.2025.101946_bib25","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/s41577-023-00871-z","article-title":"The unique properties of IgG4 and its roles in health and disease","volume":"23","author":"Rispens","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.smim.2025.101946_bib26","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.4049\/jimmunol.1801622","article-title":"Biased N-Glycosylation Site Distribution and Acquisition across the Antibody V Region during B Cell Maturation","volume":"202","author":"Koers","year":"2019","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.smim.2025.101946_bib27","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jaci.2016.06.040","article-title":"Antibody-encoding repertoires of bone marrow and peripheral blood-a focus on IgE","volume":"139","author":"Levin","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.smim.2025.101946_bib28","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.3389\/fimmu.2019.01543","article-title":"Peripheral IgE Repertoires of Healthy Donors Carry Moderate Mutation Loads and Do Not Overlap With Other Isotypes","volume":"10","author":"Koning","year":"2019","journal-title":"Front Immunol."},{"issue":"7","key":"10.1016\/j.smim.2025.101946_bib29","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1136\/ard-2023-224103","article-title":"Immune response to post-translationally modified proteins in rheumatoid arthritis: what makes it special?","volume":"83","author":"van der Woude","year":"2024","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.smim.2025.101946_bib30","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1038\/s41467-024-47337-x","article-title":"Antigen-specific Fab profiling achieves molecular-resolution analysis of human autoantibody repertoires in rheumatoid arthritis","volume":"15","author":"Stork","year":"2024","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.smim.2025.101946_bib31","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/art.42098","article-title":"IgG anti\u2013citrullinated protein antibody variable domain glycosylation increases before the onset of rheumatoid arthritis and stabilizes thereafter: a cross-sectional study encompassing\u223c 1,500 samples","volume":"74","author":"Kissel","year":"2022","journal-title":"Arthritis Rheumatol."},{"issue":"6","key":"10.1016\/j.smim.2025.101946_bib32","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1136\/annrheumdis-2017-212052","article-title":"B-cell receptor sequencing of anti-citrullinated protein antibody (ACPA) IgG-expressing B cells indicates a selective advantage for the introduction of N-glycosylation sites during somatic hypermutation","volume":"77","author":"Vergroesen","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.smim.2025.101946_bib33","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1136\/annrheumdis-2013-205109","article-title":"Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies","volume":"73","author":"Jiang","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"42","key":"10.1016\/j.smim.2025.101946_bib34","doi-asserted-by":"crossref","first-page":"17372","DOI":"10.1073\/pnas.1114465108","article-title":"Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage","volume":"108","author":"Shi","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"10.1016\/j.smim.2025.101946_bib35","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/art.38335","article-title":"Antibodies to IgG4 hinge can be found in rheumatoid arthritis patients during all stages of disease and may exacerbate chronic antibody-mediated inflammation","volume":"66","author":"van de Stadt","year":"2014","journal-title":"Arthritis Rheuma"},{"key":"10.1016\/j.smim.2025.101946_bib36","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/art.40920","article-title":"N-linked glycans in the variable domain of IgG anti\u2013citrullinated protein antibodies predict the development of rheumatoid arthritis","volume":"71","author":"Hafkenscheid","year":"2019","journal-title":"Arthritis Rheuma"},{"issue":"2","key":"10.1016\/j.smim.2025.101946_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213215","article-title":"Immunoglobulins G from patients with ANCA-associated vasculitis are atypically glycosylated in both the Fc and Fab regions and the relation to disease activity","volume":"14","author":"Lardinois","year":"2019","journal-title":"PLOS ONE"},{"key":"10.1016\/j.smim.2025.101946_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2172-13-10","article-title":"Influence of variable domain glycosylation on anti-neutrophil cytoplasmic autoantibodies and anti-glomerular basement membrane autoantibodies","volume":"13","author":"Xu","year":"2012","journal-title":"Bmc Immunol."},{"issue":"2","key":"10.1016\/j.smim.2025.101946_bib39","doi-asserted-by":"crossref","first-page":"514","DOI":"10.4049\/jimmunol.1302644","article-title":"Ig gene analysis reveals altered selective pressures on Ig-producing cells in parotid glands of primary Sjogren's syndrome patients","volume":"194","author":"Hamza","year":"2015","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.smim.2025.101946_bib40","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2017-212568","article-title":"Acquiring new N-glycosylation sites in variable regions of immunoglobulin genes by somatic hypermutation is a common feature of autoimmune diseases","volume":"77","author":"Visser","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.smim.2025.101946_bib41","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1592\/phco.30.4.339","article-title":"Meta-analysis of the efficacy and safety of adalimumab, etanercept, and infliximab for the treatment of rheumatoid arthritis","volume":"30","author":"Wiens","year":"2010","journal-title":"Pharmacother.: J. Hum. Pharmacol. Drug Ther."},{"issue":"12","key":"10.1016\/j.smim.2025.101946_bib42","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1093\/rheumatology\/kem261","article-title":"Monitoring patients treated with anti-TNF-alpha biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies","volume":"46","author":"Svenson","year":"2007","journal-title":"Rheumatol. (Oxf. )"},{"issue":"5","key":"10.1016\/j.smim.2025.101946_bib43","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1007\/s10875-012-9705-0","article-title":"IgG4 production against adalimumab during long term treatment of RA patients","volume":"32","author":"van Schouwenburg","year":"2012","journal-title":"J. Clin. Immunol."},{"issue":"4","key":"10.1016\/j.smim.2025.101946_bib44","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2222.1986.tb01963.x","article-title":"Sub-class of IgG anti-bee venom antibody produced during bee venom immunotherapy and its relationship to long-term protection from bee stings and following termination of venom immunotherapy","volume":"16","author":"Urbanek","year":"1986","journal-title":"Clin. Exp. Allergy"},{"issue":"1","key":"10.1016\/j.smim.2025.101946_bib45","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41584-022-00867-4","article-title":"Glycobiology of rheumatic diseases","volume":"19","author":"Kissel","year":"2023","journal-title":"Nat. Rev. Rheuma"},{"issue":"7","key":"10.1016\/j.smim.2025.101946_bib46","first-page":"2562","article-title":"Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma","volume":"99","author":"Zhu","year":"2002","journal-title":"Blood, J. Am. Soc. Hematol."},{"issue":"1","key":"10.1016\/j.smim.2025.101946_bib47","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41572-019-0132-x","article-title":"Follicular lymphoma","volume":"5","author":"Carbone","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"21","key":"10.1016\/j.smim.2025.101946_bib48","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.1073\/pnas.82.21.7439","article-title":"Nucleotide sequence of at (14; 18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18","volume":"82","author":"Cleary","year":"1985","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.smim.2025.101946_bib49","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/bs.ai.2021.05.002","article-title":"Follicular lymphoma dynamics","volume":"150","author":"Milpied","year":"2021","journal-title":"Adv. Immunol."},{"issue":"10","key":"10.1016\/j.smim.2025.101946_bib50","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1016\/j.jid.2019.04.005","article-title":"Acquired N-linked glycosylation motifs in B-cell receptors of primary cutaneous B-cell lymphoma and the normal B-cell repertoire","volume":"139","author":"Koning","year":"2019","journal-title":"J. Invest. Dermatol."},{"issue":"11","key":"10.1016\/j.smim.2025.101946_bib51","first-page":"834","article-title":"IGHV sequencing reveals acquired N-glycosylation sites as a clonal and stable event during follicular lymphoma evolution","volume":"135","author":"Odabashian","year":"2020","journal-title":"Blood, J. Am. Soc. Hematol."},{"issue":"17","key":"10.1016\/j.smim.2025.101946_bib52","first-page":"1570","article-title":"Insertion of atypical glycans into the tumor antigen-binding site identifies DLBCLs with distinct origin and behavior","volume":"138","author":"Chiodin","year":"2021","journal-title":"Blood, J. Am. Soc. Hematol."},{"issue":"2","key":"10.1016\/j.smim.2025.101946_bib53","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1046\/j.1365-2141.2003.04064.x","article-title":"Incidence of potential glycosylation sites in immunoglobulin variable regions distinguishes between subsets of Burkitt's lymphoma and mucosa-associated lymphoid tissue lymphoma","volume":"120","author":"Zhu","year":"2003","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/j.smim.2025.101946_bib54","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/j.1460-2075.1984.tb01955.x","article-title":"Ordered rearrangement of immunoglobulin heavy chain variable region segments","volume":"3","author":"Alt","year":"1984","journal-title":"EMBO J."},{"issue":"5909","key":"10.1016\/j.smim.2025.101946_bib55","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/302575a0","article-title":"Somatic generation of antibody diversity","volume":"302","author":"Tonegawa","year":"1983","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.smim.2025.101946_bib56","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/intimm\/9.4.515","article-title":"The role of recombination signal sequences in the preferential joining by deletion in DH-JH recombination and in the ordered rearrangement of the IgH locus","volume":"9","author":"Pan","year":"1997","journal-title":"Int. Immunol."},{"issue":"9","key":"10.1016\/j.smim.2025.101946_bib57","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.4049\/jimmunol.175.9.5912","article-title":"Ig gene rearrangement steps are initiated in early human precursor B cell subsets and correlate with specific transcription factor expression","volume":"175","author":"Van Zelm","year":"2005","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2025.101946_bib58","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/nar\/27.1.209","article-title":"IMGT, the international ImMunoGeneTics database","volume":"27","author":"Lefranc","year":"1999","journal-title":"Nucleic Acids Res."},{"issue":"3-4","key":"10.1016\/j.smim.2025.101946_bib59","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0161-5890(00)00038-9","article-title":"Effect of somatic hypermutation on potential N-glycosylation sites in human immunoglobulin heavy chain variable regions","volume":"37","author":"Dunn-Walters","year":"2000","journal-title":"Mol. Immunol."},{"issue":"6893","key":"10.1016\/j.smim.2025.101946_bib60","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature00862","article-title":"AID mutates E. coli suggesting a DNA deamination mechanism for antibody diversification","volume":"418","author":"Petersen-Mahrt","year":"2002","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.smim.2025.101946_bib61","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.coi.2013.05.017","article-title":"Mechanisms regulating the targeting and activity of activation induced cytidine deaminase","volume":"25","author":"Fear","year":"2013","journal-title":"Curr. Opin. Immunol."},{"issue":"4","key":"10.1016\/j.smim.2025.101946_bib62","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1084\/jem.20050872","article-title":"Inducible DNA breaks in Ig S regions are dependent on AID and UNG","volume":"202","author":"Schrader","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2025.101946_bib63","doi-asserted-by":"crossref","DOI":"10.1093\/emboj\/18.12.3484","article-title":"and M.S. Neuberger, Deficiency in Msh2 affects the efficiency and local sequence specificity of immunoglobulin class-switch recombination: parallels with somatic hypermutation.","author":"Ehrenstein","year":"1999","journal-title":"EMBO J."},{"issue":"8","key":"10.1016\/j.smim.2025.101946_bib64","doi-asserted-by":"crossref","first-page":"6496","DOI":"10.1074\/jbc.M311616200","article-title":"DNA substrate length and surrounding sequence affect the activation-induced deaminase activity at cytidine","volume":"279","author":"Yu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2025.101946_bib65","doi-asserted-by":"crossref","first-page":"788","DOI":"10.3389\/fimmu.2020.00788","article-title":"AID overlapping and Pol\u03b7 hotspots are key features of evolutionary variation within the human antibody heavy chain (IGHV) genes","volume":"11","author":"Tang","year":"2020","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.smim.2025.101946_bib66","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.4049\/jimmunol.1801622","article-title":"Biased N-glycosylation site distribution and acquisition across the antibody V region during B cell maturation","volume":"202","author":"Koers","year":"2019","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.smim.2025.101946_bib67","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nrrheum.2011.204","article-title":"The influence of ACPA status and characteristics on the course of RA","volume":"8","author":"Willemze","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"issue":"2","key":"10.1016\/j.smim.2025.101946_bib68","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum.: Off. J. Am. Coll. Rheumatol."},{"key":"10.1016\/j.smim.2025.101946_bib69","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.clim.2017.09.001","article-title":"Variable domain glycosylation of ACPA-IgG: A missing link in the maturation of the ACPA response?","volume":"186","author":"Kempers","year":"2018","journal-title":"Clin. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2025.101946_bib70","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/annrheumdis-2021-220841","article-title":"Genetic predisposition (HLA-SE) is associated with ACPA-IgG variable domain glycosylation in the predisease phase of RA","volume":"81","author":"Kissel","year":"2022","journal-title":"Ann. Rheum. Dis."},{"issue":"4","key":"10.1016\/j.smim.2025.101946_bib71","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/sj.leu.2403323","article-title":"Activation-induced cytidine deaminase expression in follicular lymphoma: association between AID expression and ongoing mutation in FL","volume":"18","author":"Hardianti","year":"2004","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.smim.2025.101946_bib72","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3109\/10428194.2015.1037758","article-title":"Isotype-switched follicular lymphoma displays dissociation between activation-induced cytidine deaminase expression and somatic hypermutation","volume":"57","author":"Scherer","year":"2016","journal-title":"Leuk. Lymphoma"},{"issue":"1-2","key":"10.1016\/j.smim.2025.101946_bib73","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jim.2012.05.022","article-title":"Quantitative glycan profiling of normal human plasma derived immunoglobulin and its fragments Fab and Fc","volume":"382","author":"Anumula","year":"2012","journal-title":"J. Immunol. Methods"},{"issue":"9","key":"10.1016\/j.smim.2025.101946_bib74","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.4049\/jimmunol.1300179","article-title":"Nonstereotyped lymphoma B cell receptors recognize vimentin as a shared autoantigen","volume":"190","author":"Cha","year":"2013","journal-title":"J. Immunol."},{"issue":"21","key":"10.1016\/j.smim.2025.101946_bib75","first-page":"3287","article-title":"Lectins from opportunistic bacteria interact with acquired variable-region glycans of surface immunoglobulin in follicular lymphoma","volume":"125","author":"Schneider","year":"2015","journal-title":"Blood, J. Am. Soc. Hematol."},{"issue":"43","key":"10.1016\/j.smim.2025.101946_bib76","doi-asserted-by":"crossref","first-page":"18587","DOI":"10.1073\/pnas.1009388107","article-title":"Glycosylation of surface Ig creates a functional bridge between human follicular lymphoma and microenvironmental lectins","volume":"107","author":"Coelho","year":"2010","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"10","key":"10.1016\/j.smim.2025.101946_bib77","doi-asserted-by":"crossref","first-page":"7405","DOI":"10.1074\/jbc.M602690200","article-title":"Human follicular lymphoma cells contain oligomannose glycans in the antigen-binding site of the B-cell receptor","volume":"282","author":"Radcliffe","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"19","key":"10.1016\/j.smim.2025.101946_bib78","doi-asserted-by":"crossref","first-page":"5812","DOI":"10.1182\/bloodadvances.2023010725","article-title":"Acquisition of a glycosylated B-cell receptor drives follicular lymphoma toward a dark zone phenotype","volume":"7","author":"Van Bergen","year":"2023","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.smim.2025.101946_bib79","first-page":"40","article-title":"Transformed follicular non-Hodgkin lymphoma","volume":"125","author":"Casulo","year":"2015","journal-title":"Blood, J. Am. Soc. Hematol."},{"issue":"6769","key":"10.1016\/j.smim.2025.101946_bib80","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature"},{"issue":"44","key":"10.1016\/j.smim.2025.101946_bib81","doi-asserted-by":"crossref","first-page":"13447","DOI":"10.1073\/pnas.1514944112","article-title":"Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens","volume":"112","author":"Young","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.smim.2025.101946_bib82","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1016\/j.ajpath.2012.07.028","article-title":"Molecular characterization of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma: antigen-driven origin and IGHV4-34 as a particular subgroup of the non-GCB subtype","volume":"181","author":"Sebasti\u00e1n","year":"2012","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.smim.2025.101946_bib83","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.molimm.2007.10.009","article-title":"Remarkable selective glycosylation of the immunoglobulin variable region in follicular lymphoma","volume":"45","author":"McCann","year":"2008","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.smim.2025.101946_bib84","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0065-230X(08)60470-4","article-title":"The pathogenesis of Burkitt's lymphoma","volume":"55","author":"Magrath","year":"1990","journal-title":"Adv. Cancer Res."},{"issue":"4","key":"10.1016\/j.smim.2025.101946_bib85","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1046\/j.1365-2141.1998.01125.x","article-title":"VH gene analysis of Burkitt's lymphoma in children from north-western Iran","volume":"103","author":"Chapman","year":"1998","journal-title":"Br. J. Haematol."},{"issue":"12","key":"10.1016\/j.smim.2025.101946_bib86","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1136\/annrheumdis-2019-215698","article-title":"On the presence of HLA-SE alleles and ACPA-IgG variable domain glycosylation in the phase preceding the development of rheumatoid arthritis","volume":"78","author":"Kissel","year":"2019","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.smim.2025.101946_bib87","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/ard.2010.135509","article-title":"Anti-citrullinated protein antibodies have a low avidity compared with antibodies against recall antigens","volume":"70","author":"Suwannalai","year":"2011","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.smim.2025.101946_bib88","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-91112-7","article-title":"DC-SIGN binding to mannosylated B-cell receptors in follicular lymphoma down-modulates receptor signaling capacity","volume":"11","author":"Valle-Argos","year":"2021","journal-title":"Sci. Rep."},{"issue":"16","key":"10.1016\/j.smim.2025.101946_bib89","first-page":"1911","article-title":"DC-SIGN\u2013expressing macrophages trigger activation of mannosylated IgM B-cell receptor in follicular lymphoma","volume":"126","author":"Amin","year":"2015","journal-title":"Blood, J. Am. Soc. Hematol."},{"issue":"16","key":"10.1016\/j.smim.2025.101946_bib90","first-page":"1902","article-title":"Lectin binding to surface Ig variable regions provides a universal persistent activating signal for follicular lymphoma cells","volume":"126","author":"Linley","year":"2015","journal-title":"Blood, J. Am. Soc. Hematol."},{"issue":"6","key":"10.1016\/j.smim.2025.101946_bib91","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abm1759","article-title":"Surface Ig variable domain glycosylation affects autoantigen binding and acts as threshold for human autoreactive B cell activation","volume":"8","author":"Kissel","year":"2022","journal-title":"Sci. Adv."},{"issue":"7","key":"10.1016\/j.smim.2025.101946_bib92","doi-asserted-by":"crossref","first-page":"a002295","DOI":"10.1101\/cshperspect.a002295","article-title":"It\u2019s all about change: The antigen-driven initiation of B cell receptor signaling","volume":"2","author":"Liu","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"7314","key":"10.1016\/j.smim.2025.101946_bib93","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nature09357","article-title":"Oligomeric organization of the B-cell antigen receptor on resting cells","volume":"467","author":"Yang","year":"2010","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.smim.2025.101946_bib94","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1016\/j.febslet.2010.09.045","article-title":"The dissociation activation model of B cell antigen receptor triggering","volume":"584","author":"Yang","year":"2010","journal-title":"FEBS Lett."},{"issue":"6","key":"10.1016\/j.smim.2025.101946_bib95","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/eji.1830230626","article-title":"Association of CD22 with the B cell antigen receptor","volume":"23","author":"Peaker","year":"1993","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2025.101946_bib96","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1600-065X.2009.00801.x","article-title":"CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions","volume":"230","author":"Nitschke","year":"2009","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.smim.2025.101946_bib97","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.coi.2005.03.005","article-title":"The role of CD22 and other inhibitory co-receptors in B-cell activation","volume":"17","author":"Nitschke","year":"2005","journal-title":"Curr. Opin. Immunol."},{"issue":"30","key":"10.1016\/j.smim.2025.101946_bib98","doi-asserted-by":"crossref","first-page":"12402","DOI":"10.1073\/pnas.1304888110","article-title":"CD22 ligand-binding and signaling domains reciprocally regulate B-cell Ca2+\u2009signaling","volume":"110","author":"Muller","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.smim.2025.101946_bib99","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02820","article-title":"B Cell Siglecs\u2013News on Signaling and Its Interplay With Ligand Binding","volume":"9","author":"Meyer","year":"2018","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.smim.2025.101946_bib100","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nchembio713","article-title":"Homomultimeric complexes of CD22 in B cells revealed by protein-glycan cross-linking","volume":"1","author":"Han","year":"2005","journal-title":"Nat. Chem. Biol."},{"issue":"9","key":"10.1016\/j.smim.2025.101946_bib101","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/glycob\/cwad055","article-title":"A photoaffinity glycan-labeling approach to investigate immunoglobulin glycan-binding partners","volume":"33","author":"Holborough-Kerkvliet","year":"2023","journal-title":"Glycobiology"},{"issue":"1","key":"10.1016\/j.smim.2025.101946_bib102","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/s41467-017-00836-6","article-title":"Molecular basis of human CD22 function and therapeutic targeting","volume":"8","author":"Ereno-Orbea","year":"2017","journal-title":"Nat. Commun."},{"issue":"52","key":"10.1016\/j.smim.2025.101946_bib103","doi-asserted-by":"crossref","first-page":"20249","DOI":"10.1074\/jbc.RA118.004636","article-title":"Galectin binding to cells and glycoproteins with genetically modified glycosylation reveals galectin\u2013glycan specificities in a natural context","volume":"293","author":"Nielsen","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.smim.2025.101946_bib104","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-05770-9","article-title":"Galectin-9 suppresses B cell receptor signaling and is regulated by I-branching of N-glycans","volume":"9","author":"Giovannone","year":"2018","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.smim.2025.101946_bib105","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1084\/jem.168.3.1099","article-title":"Glycosylation of a VH residue of a monoclonal antibody against alpha (1----6) dextran increases its affinity for antigen","volume":"168","author":"Wallick","year":"1988","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2025.101946_bib106","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1007980032042","article-title":"Building high affinity human antibodies by altering the glycosylation on the light chain variable region in N-acetylglucosamine-supplemented hybridoma cultures","volume":"23","author":"Tachibana","year":"1997","journal-title":"Cytotechnology"},{"issue":"2","key":"10.1016\/j.smim.2025.101946_bib107","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1042\/bj3380529","article-title":"Variable domain-linked oligosaccharides of a human monoclonal IgG: structure and influence on antigen binding","volume":"338","author":"Leibiger","year":"1999","journal-title":"Biochem. J."},{"issue":"10","key":"10.1016\/j.smim.2025.101946_bib108","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1002\/j.1460-2075.1991.tb07819.x","article-title":"Antibody variable region glycosylation: position effects on antigen binding and carbohydrate structure","volume":"10","author":"Wright","year":"1991","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.smim.2025.101946_bib109","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.4049\/jimmunol.162.4.2162","article-title":"Position effects of variable region carbohydrate on the affinity and in vivo behavior of an anti-(1\u2192 6) dextran antibody","volume":"162","author":"Coloma","year":"1999","journal-title":"J. Immunol."},{"issue":"25","key":"10.1016\/j.smim.2025.101946_bib110","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1406974111","article-title":"Redemption of autoantibodies on anergic B cells by variable-region glycosylation and mutation away from self-reactivity","volume":"111","author":"Sabouri","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.smim.2025.101946_bib111","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jpba.2016.03.029","article-title":"Generation and characterization of a unique panel of anti-adalimumab specific antibodies and their application in therapeutic drug monitoring assays","volume":"125","author":"Bian","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"50","key":"10.1016\/j.smim.2025.101946_bib112","doi-asserted-by":"crossref","first-page":"34482","DOI":"10.1074\/jbc.M114.615500","article-title":"Functional Analysis of the Anti-adalimumab Response Using Patient-derived Monoclonal Antibodies\u2666","volume":"289","author":"van Schouwenburg","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.smim.2025.101946_bib113","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3389\/fimmu.2018.00740","article-title":"Variable Domain N-Linked Glycans Acquired During Antigen-Specific Immune Responses Can Contribute to Immunoglobulin G Antibody Stability","author":"van de Bovenkamp","year":"2018","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.smim.2025.101946_bib114","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/19420862.2015.1112477","article-title":"Rational design of therapeutic mAbs against aggregation through protein engineering and incorporation of glycosylation motifs applied to bevacizumab","volume":"8","author":"Courtois","year":"2016","journal-title":"mAbs"},{"issue":"8","key":"10.1016\/j.smim.2025.101946_bib115","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/protein\/gzq037","article-title":"Structure-based engineering of a monoclonal antibody for improved solubility","volume":"23","author":"Wu","year":"2010","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.smim.2025.101946_bib116","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3389\/fimmu.2017.00877","article-title":"Decoding the Human Immunoglobulin G-Glycan Repertoire Reveals a Spectrum of Fc-Receptor- and Complement-Mediated-Effector Activities","volume":"8","author":"Dekkers","year":"2017","journal-title":"Front Immunol."},{"issue":"2","key":"10.1016\/j.smim.2025.101946_bib117","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/intimm\/dxg018","article-title":"Evidence to support the cellular mechanism involved in serum IgG homeostasis in humans","volume":"15","author":"Ward","year":"2003","journal-title":"Int. Immunol."},{"issue":"7","key":"10.1016\/j.smim.2025.101946_bib118","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1002\/eji.1830260718","article-title":"An IgG-transporting Fc receptor expressed in the syncytiotrophoblast of human placenta","volume":"26","author":"Simister","year":"1996","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.smim.2025.101946_bib119","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4049\/jimmunol.2200438","article-title":"IgG Fab Glycans Hinder FcRn-Mediated Placental Transport","volume":"210","author":"Volkov","year":"2023","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2025.101946_bib120","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-33764-1","article-title":"The Fab region of IgG impairs the internalization pathway of FcRn upon Fc engagement","volume":"13","author":"Brinkhaus","year":"2022","journal-title":"Nat. Commun."},{"issue":"23","key":"10.1016\/j.smim.2025.101946_bib121","doi-asserted-by":"crossref","first-page":"12943","DOI":"10.1073\/pnas.2004325117","article-title":"FcRn, but not FcgammaRs, drives maternal-fetal transplacental transport of human IgG antibodies","volume":"117","author":"Borghi","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.smim.2025.101946_bib122","first-page":"2020","article-title":"Update on Transplacental Transfer of IgG Subclasses: Impact of Maternal and Fetal Factors","volume":"11","author":"Clements","year":"1920","journal-title":"Front Immunol."},{"issue":"2","key":"10.1016\/j.smim.2025.101946_bib123","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/uog.24891","article-title":"Targeting neonatal Fc receptor: potential clinical applications in pregnancy","volume":"60","author":"Moise","year":"2022","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"19","key":"10.1016\/j.smim.2025.101946_bib124","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.1073\/pnas.1408766112","article-title":"Charge-mediated influence of the antibody variable domain on FcRn-dependent pharmacokinetics","volume":"112","author":"Schoch","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.smim.2025.101946_bib125","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/19420862.2017.1389355","article-title":"Changes in complementarity-determining regions significantly alter IgG binding to the neonatal Fc receptor (FcRn) and pharmacokinetics","volume":"10","author":"Piche-Nicholas","year":"2018","journal-title":"MAbs"},{"issue":"3","key":"10.1016\/j.smim.2025.101946_bib126","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1074\/mcp.M116.064675","article-title":"A Two-pronged Binding Mechanism of IgG to the Neonatal Fc Receptor Controls Complex Stability and IgG Serum Half-life","volume":"16","author":"Jensen","year":"2017","journal-title":"Mol. Cell Proteom."},{"issue":"2","key":"10.1016\/j.smim.2025.101946_bib127","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-004278","article-title":"Nipocalimab, an anti-FcRn monoclonal antibody, in participants with moderate to severe active rheumatoid arthritis and inadequate response or intolerance to anti-TNF therapy: results from the phase 2a IRIS-RA study","volume":"10","author":"Taylor","year":"2024","journal-title":"RMD Open"}],"container-title":["Seminars in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532325000181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532325000181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:47:28Z","timestamp":1762354048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044532325000181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":127,"alternative-id":["S1044532325000181"],"URL":"https:\/\/doi.org\/10.1016\/j.smim.2025.101946","relation":{},"ISSN":["1044-5323"],"issn-type":[{"value":"1044-5323","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variable domain glycosylation as a marker and modulator of immune responses: Insights into autoimmunity and B-cell malignancies","name":"articletitle","label":"Article Title"},{"value":"Seminars in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smim.2025.101946","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101946"}}